No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Telehealth Virtual Visits Software is Launched by Seattle Based MedBridge

Editor: What To Know

  • The Virtual Visit software is part of the complete MedBridge Digital Patient Engagement Suite, which includes program adherence tracking, in-app messaging, and satisfaction monitoring to help patients self-manage and stay active in their plan of care while they’re confined to their home.
  • The offer is intended to provide crucial help to healthcare organizations and their patients throughout the COVID-19 crisis by allowing providers to manage the care of their patients remotely.
  • We're committed to helping everyone weather this crisis and stay prepared during every stage with innovative solutions for remote care and education as we all adjust to a new paradigm,” said Justin Kowalchuk, CEO, and founder of MedBridge.

The offer is intended to provide crucial help to healthcare organizations and their patients throughout the COVID-19 crisis by allowing providers to manage the care of their patients remotely.

Healthcare organizations and professionals across the care continuum are now being confronted with equally difficult challenges. Many outpatient organizations are experiencing steep revenue loss as patients cancel or defer appointments due to quarantine, social distancing protocols, and concerns overexposure. Post-acute care clients, including those in skilled nursing and home health, must adjust care delivery to keep both their staff and patients safe. In response, MedBridge launched its Telehealth solution to be available as a beta version several months sooner than planned.

MedBridge is here to support our customers, their patients, and their communities during this challenging time and beyond. We’re committed to helping everyone weather this crisis and stay prepared during every stage with innovative solutions for remote care and education as we all adjust to a new paradigm,” said Justin Kowalchuk, CEO, and founder of MedBridge.

MedBridge Telehealth allows providers to remotely screen, triage, and care for patients in real-time, providing a HIPAA-compliant method for continuing treatment plans during the ongoing COVID-19 crisis. Providers can also foster rapport, engagement, and education by building, sharing, and discussing targeted home exercises with their patients during each virtual visit.

“Telehealth Virtual Visits offers a patient experience that’s as close as possible to an in-person session. It’s easy to implement, use, and learn for clinicians and patients, which is essential now that healthcare professionals are in crisis mode. Because it allows for uninterrupted care, it can be used to optimize long-term outcomes by rehab providers across the care continuum,” said Keta Shaw, Telehealth Product Manager, MedBridge.

The Virtual Visit software is part of the complete MedBridge Digital Patient Engagement Suite, which includes program adherence tracking, in-app messaging, and satisfaction monitoring to help patients self-manage and stay active in their plan of care while they’re confined to their home. The virtual patient care solution, paired with MedBridge’s remote training, infection prevention, and crisis management education, offers healthcare organizations a complete solution to combat the challenges of this time.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy